Hanger (NYSE:HNGR) - Cours de l'action, nouvelles et analyse

This company has been acquired

The company may no longer be operating, as it has been acquired. Find out why through their latest events.

La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

HNGR Aperçu des actions

Hanger, Inc. provides orthotic and prosthetic (O&P) services in the United States.

HNGR analyse fondamentale
Score flocon de neige
Évaluation	1/6
Croissance future	0/6
Performances passées	4/6
Santé financière	2/6
Dividendes	0/6

Récompenses

Earnings grew by 25.5% over the past year

Analyse des risques

Interest payments are not well covered by earnings

Hanger, Inc. Concurrents

National HealthCare

NYSEAM:NHC

US$1.9b

U.S. Physical Therapy

NYSE:USPH

US$1.2b

Select Medical Holdings

NYSE:SEM

US$4.4b

Joint

NasdaqCM:JYNT

US$164.5m

Historique des prix et performances

Résumé des plus hauts, des changements et des baisses de prix pour Hanger
Historique des cours de bourse
Prix actuel de l'action	US$18.72
Plus haut sur 52 semaines	US$22.67
Plus bas sur 52 semaines	US$13.42
Bêta	1.36
1Variation sur 1 mois	0.32%
Variation sur 3 mois	27.35%
Variation sur 1 an	-14.17%
3Variation sur 3 ans	-4.00%
Variation sur 5 ans	70.18%
Évolution depuis l'introduction en bourse	284.00%

Nouvelles et mises à jour récentes

Hanger stock jumps postmarket on deal to be taken private at $1.25B enterprise value

Jul 21

Recent updates

Hanger stock jumps postmarket on deal to be taken private at $1.25B enterprise value

Jul 21

If You Had Bought Hanger (NYSE:HNGR) Shares Five Years Ago You'd Have Earned 67% Returns

Feb 19

Here’s What’s Happening With Returns At Hanger (NYSE:HNGR)

Jan 25

Hanger (NYSE:HNGR) Has A Pretty Healthy Balance Sheet

Jan 07

Here's Why We Think Hanger (NYSE:HNGR) Is Well Worth Watching

Dec 21

Should You Use Hanger's (NYSE:HNGR) Statutory Earnings To Analyse It?

Dec 06

Rendement pour les actionnaires

	HNGR	US Healthcare	US Marché
7D	0%	-1.2%	0.3%
1Y	-14.2%	8.2%	32.4%

Rendement vs Industrie: HNGR underperformed the US Healthcare industry which returned 7.7% over the past year.

Rendement vs marché: HNGR exceeded the US Market which returned -23.2% over the past year.

Volatilité des prix

Is HNGR's price volatile compared to industry and market?
HNGR volatility
HNGR Average Weekly Movement	7.4%
Healthcare Industry Average Movement	7.1%
Market Average Movement	6.4%
10% most volatile stocks in US Market	15.0%
10% least volatile stocks in US Market	3.1%

Cours de l'action stable: HNGR has not had significant price volatility in the past 3 months.

Volatilité au fil du temps: HNGR's weekly volatility (7%) has been stable over the past year.

À propos de l'entreprise

Fondée	Salariés	PDG	Site web
1861	5,200	Vinit Asar	hangerclinic.com

Hanger, Inc. Résumé des fondamentaux

Comment les bénéfices et les revenus de Hanger se comparent-ils à sa capitalisation boursière ?
HNGR statistiques fondamentales
Capitalisation boursière	US$732.39m
Bénéfices(TTM)	US$37.29m
Recettes(TTM)	US$1.18b

19.6x

Ratio P/E

0.6x

Ratio P/S

Le site HNGR est-il surévalué ?

Voir Juste valeur et analyse de l'évaluation

Bénéfices et recettes

Principales statistiques de rentabilité tirées du dernier rapport sur les bénéfices (TTM)
HNGR compte de résultat (TTM)
Recettes	US$1.18b
Coût des recettes	US$796.67m
Marge brute	US$378.85m
Autres dépenses	US$341.55m
Les revenus	US$37.29m

Derniers bénéfices déclarés

Jun 30, 2022

Prochaine date de publication des résultats

s/o

Résultat par action (EPS)	0.95
Marge brute	32.23%
Marge bénéficiaire nette	3.17%
Ratio dettes/capitaux propres	381.4%

Quelles ont été les performances à long terme de HNGR?

Voir les performances historiques et les comparaisons

This company has been acquired

HNGR Aperçu des actions

Récompenses

Analyse des risques

Hanger, Inc. Concurrents

NYSEAM:NHC

US$1.9b

NYSE:USPH

US$1.2b

NYSE:SEM

US$4.4b

NasdaqCM:JYNT

US$164.5m

Historique des prix et performances

Nouvelles et mises à jour récentes

Second quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Patient Square Capital, LP entered into a definitive agreement to acquire Hanger, Inc. (NYSE:HNGR) for approximately $760 million.

Investor sentiment improved over the past week

Patient Square Capital, LP entered into a definitive agreement to acquire Hanger, Inc. (NYSE:HNGR) for an enterprise value of $1.25 billion.

Hanger stock jumps postmarket on deal to be taken private at $1.25B enterprise value

Hanger, Inc. to Report Q2, 2022 Results on Aug 08, 2022

Recent updates

Second quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Patient Square Capital, LP entered into a definitive agreement to acquire Hanger, Inc. (NYSE:HNGR) for approximately $760 million.

Investor sentiment improved over the past week

Patient Square Capital, LP entered into a definitive agreement to acquire Hanger, Inc. (NYSE:HNGR) for an enterprise value of $1.25 billion.

Hanger stock jumps postmarket on deal to be taken private at $1.25B enterprise value

Hanger, Inc. to Report Q2, 2022 Results on Aug 08, 2022

Is It Too Late To Consider Buying Hanger, Inc. (NYSE:HNGR)?

Returns At Hanger (NYSE:HNGR) Are On The Way Up

First quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Hanger, Inc. Reaffirms Earnings Guidance for the Year 2022

Calculating The Fair Value Of Hanger, Inc. (NYSE:HNGR)

Price target decreased to US$26.00

Hanger, Inc. to Report Q1, 2022 Results on May 04, 2022

Hanger, Inc., Annual General Meeting, May 19, 2022

Senior VP & Chief Clinical Officer recently sold US$78k worth of stock

Full year 2021 earnings: EPS exceeds analyst expectations

Hanger, Inc. Provides Revenue Guidance for 2022

CFO & Executive VP notifies of intention to sell stock

Third quarter 2021 earnings released: EPS US$0.55 (vs US$0.18 in 3Q 2020)

The Return Trends At Hanger (NYSE:HNGR) Look Promising

Should You Investigate Hanger, Inc. (NYSE:HNGR) At US$20.98?

CFO & Executive VP notifies of intention to sell stock

CEO, President & Director notifies of intention to sell stock

Investor sentiment deteriorated over the past week

Here's Why Hanger (NYSE:HNGR) Has A Meaningful Debt Burden

Second quarter 2021 earnings released: EPS US$0.26 (vs US$0.82 in 2Q 2020)

Hanger, Inc. Provides Earnings Outlook for the Year 2021

I Ran A Stock Scan For Earnings Growth And Hanger (NYSE:HNGR) Passed With Ease

Hanger, Inc.(NYSE:HNGR) dropped from Russell 3000E Value Index

Returns On Capital Are Showing Encouraging Signs At Hanger (NYSE:HNGR)

CFO & Executive VP notifies of intention to sell stock

Insider exercised options and sold US$417k worth of stock

Price target increased to US$29.00

Increases to Hanger, Inc.'s (NYSE:HNGR) CEO Compensation Might Cool off for now

Senior VP exercised options and sold US$610k worth of stock

First quarter 2021 earnings released: US$0.087 loss per share (vs US$0.42 loss in 1Q 2020)

Hanger, Inc. Re-Affirms Earnings Guidance for the Full Year of 2021

VP & Chief Accounting Officer exercised options and sold US$257k worth of stock

Is Hanger (NYSE:HNGR) A Risky Investment?

Is It Time To Consider Buying Hanger, Inc. (NYSE:HNGR)?

Here's Why I Think Hanger (NYSE:HNGR) Might Deserve Your Attention Today

New 90-day high: US$24.65

Why Hanger, Inc. (NYSE:HNGR) Looks Like A Quality Company

Analysts update estimates

Full year 2020 earnings released: EPS US$1.01 (vs US$0.74 in FY 2019)

Revenue and earnings beat expectations

If You Had Bought Hanger (NYSE:HNGR) Shares Five Years Ago You'd Have Earned 67% Returns

Hanger, Inc. to Report Q4, 2020 Results on Mar 01, 2021

Here’s What’s Happening With Returns At Hanger (NYSE:HNGR)

Hanger (NYSE:HNGR) Has A Pretty Healthy Balance Sheet

New 90-day high: US$24.49

Here's Why We Think Hanger (NYSE:HNGR) Is Well Worth Watching

Price target raised to US$25.50

New 90-day high: US$23.88

Should You Use Hanger's (NYSE:HNGR) Statutory Earnings To Analyse It?

New 90-day high: US$21.80

Revenue and earnings beat expectations

Third quarter 2020 earnings released: EPS US$0.18